In the first published study of its kind, Tonalin® CLA improved airway hyper-reactivity in overweight mild asthmatics accompanied by a significant improvement in their tolerance for strenuous exercise.
Adults taking Tonalin® CLA also reduced their body weight and BMI by 2 kg (4.4 lbs) and 0.5 kg/m over time which was associated with a metabolically favorable change in adipokine concentrations. The reductions observed in the CLA group were significantly different from the placebo group confirming once again the beneficial impact of CLA for weight and body fat management.
The prospective, randomized, double-blind, placebo-controlled intervention trial, published in the July edition of the Journal of Clinical & Experimental Allergy, was conducted by a team of researchers at the University of British Colombia, Vancouver, Canada.
No comments:
Post a Comment